CAPTRUST FINANCIAL ADVISORS - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 375 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$511,364
+9.8%
10,108
-1.5%
0.00%0.0%
Q3 2023$465,666
+21.7%
10,266
+10.1%
0.00%0.0%
Q2 2023$382,687
+13.2%
9,327
-1.4%
0.00%
+100.0%
Q1 2023$338,029
-6.1%
9,458
-0.7%
0.00%
-50.0%
Q4 2022$359,873
+579.0%
9,528
+566.8%
0.00%
Q2 2022$53,000
+20.5%
1,429
+21.1%
0.00%
Q1 2022$44,000
+10.0%
1,180
-9.3%
0.00%
Q4 2021$40,000
-51.8%
1,301
-47.4%
0.00%
-100.0%
Q3 2021$83,000
+9.2%
2,472
+30.4%
0.00%0.0%
Q2 2021$76,000
-14.6%
1,896
-3.9%
0.00%0.0%
Q1 2021$89,000
+1.1%
1,973
+27.0%
0.00%0.0%
Q4 2020$88,000
+18.9%
1,5530.0%0.00%0.0%
Q3 2020$74,000
-20.4%
1,5530.0%0.00%
-50.0%
Q2 2020$93,000
+36.8%
1,553
+7.2%
0.00%
+100.0%
Q1 2020$68,000
+126.7%
1,449
+192.1%
0.00%0.0%
Q3 2019$30,000
+130.8%
496
+153.1%
0.00%
Q2 2019$13,000
+333.3%
196
+366.7%
0.00%
Q1 2019$3,000
-40.0%
42
-51.2%
0.00%
Q4 2018$5,000
+25.0%
860.0%0.00%
Q3 2018$4,0000.0%860.0%0.00%
Q2 2018$4,0000.0%860.0%0.00%
Q4 2017$4,0000.0%860.0%0.00%
Q3 2017$4,000860.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bellevue Group AG 9,347,926$313,529,0003.18%
Sicart Associates LLC 291,254$9,769,0002.66%
Camber Capital Management LP 2,500,000$83,850,0002.58%
SECTOR GAMMA AS 263,870$8,850,0001.76%
Parkman Healthcare Partners LLC 136,380$4,574,0001.16%
Eversept Partners, LP 450,501$15,109,8041.05%
SPHERA FUNDS MANAGEMENT LTD. 350,000$11,739,0000.99%
TANAKA CAPITAL MANAGEMENT INC 16,661$559,0000.80%
Sonora Investment Management, LLC 163,703$5,491,0000.69%
ARK Investment Management 8,511,384$285,472,0000.69%
View complete list of IONIS PHARMACEUTICALS INC shareholders